Termination and beyond: acetylcholinesterase as a modulator of synaptic transmission

被引:0
作者
Gabriel Zimmerman
Hermona Soreq
机构
[1] The Hebrew University of Jerusalem,The Institute of Life Sciences and the Interdisciplinary Center for Neural Computation (ICNC)
来源
Cell and Tissue Research | 2006年 / 326卷
关键词
Acetylcholinesterase; Synaptic transmission; Alternative splicing; Alternate promoters; Synapse adherence;
D O I
暂无
中图分类号
学科分类号
摘要
Termination of synaptic transmission by neurotransmitter hydrolysis is a substantial characteristic of cholinergic synapses. This unique termination mechanism makes acetylcholinesterase (AChE), the enzyme in charge of executing acetylcholine breakdown, a key component of cholinergic signaling. AChE is now known to exist not as a single entity, but rather as a combinatorial complex of protein products. The diverse AChE molecular forms are generated by a single gene that produces over ten different transcripts by alternative splicing and alternative promoter choices. These transcripts are translated into six different protein subunits. Mature AChE proteins are found as soluble monomers, amphipatic dimers, or tetramers of these subunits and become associated to the cellular membrane by specialized anchoring molecules or members of other heteromeric structural components. A substantial increasing body of research indicates that AChE functions in the central nervous system go far beyond the termination of synaptic transmission. The non-enzymatic neuromodulatory functions of AChE affect neurite outgrowth and synaptogenesis and play a major role in memory formation and stress responses. The structural homology between AChE and cell adhesion proteins, together with the recently discovered protein partners of AChE, predict the future unraveling of the molecular pathways underlying these multileveled functions.
引用
收藏
页码:655 / 669
页数:14
相关论文
共 785 条
[1]  
Anglister L(1994)Acetylcholinesterase density and turnover number at frog neuromuscular junctions, with modeling of their role in synaptic function Neuron 12 783-794
[2]  
Stiles JR(1994)Evolution of acetylcholinesterase transcripts and molecular forms during development in the central nervous system of the quail J Neurochem 62 2158-2165
[3]  
Salpeter MM(1995)Acetylcholinesterase induces long-term potentiation in CA1 pyramidal cells by a mechanism dependent on metabotropic glutamate receptors Neurosci Lett 190 25-28
[4]  
Anselmet A(1992)Actions of acetylcholinesterase in the guinea-pig cerebellar cortex in vitro Neuroscience 47 291-301
[5]  
Fauquet M(1992)Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer’s disease resemble embryonic development—a study of molecular forms Neurochem Int 21 381-396
[6]  
Chatel JM(2002)Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice Nat Neurosci 5 119-123
[7]  
Maulet Y(1995)Gliotactin, a novel transmembrane protein on peripheral glia, is required to form the blood-nerve barrier in Cell 81 757-767
[8]  
Massoulie J(2002)Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine Biochemistry 41 3555-3564
[9]  
Vallette FM(1993)Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphism Am J Hum Genet 52 928-936
[10]  
Appleyard ME(1990) neurotactin mediates heterophilic cell adhesion EMBO J 9 3603-3609